NAVI
47
3
KIM
76
2
LEN
52
2
URBN
42
4
SEE
52
6
AVY
50
2
ABBV
39
8
SIG
49
6
BXP
52
2
MAR
65
2
HD
55
8
PH
73
3
BF.B
31
3
XEL
69
2
TXT
52
4
COST
63
5
SRE
66
3
COF
58
3
NTRS
57
2
KEY
43
3
NAVI
47
3
KIM
76
2
LEN
52
2
URBN
42
4
SEE
52
6
AVY
50
2
ABBV
39
8
SIG
49
6
BXP
52
2
MAR
65
2
HD
55
8
PH
73
3
BF.B
31
3
XEL
69
2
TXT
52
4
COST
63
5
SRE
66
3
COF
58
3
NTRS
57
2
KEY
43
3
Financhill
Back

Mereo BioPharma Group PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

MREO
Mereo BioPharma Group PLC

Last Price:
3.72
Seasonality Move:
12.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Mereo BioPharma Group PLC Price Quote

$3.72
+0.04 (+1.09%)
(Updated: November 22, 2024 at 1:45 PM ET)

Mereo BioPharma Group PLC Key Stats

Sell
45
Mereo BioPharma Group PLC (MREO) is a Sell
Day range:
$3.45 - $3.69
52-week range:
$1.86 - $5.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
7.87%
Volume:
723.6K
Avg. volume:
717.2K
1-year change:
61.4%
Market cap:
$570.9M
Revenue:
$10M
EPS:
$-0.3

How Much Does Mereo BioPharma Group PLC Make?

Data Unavailable

Is Mereo BioPharma Group PLC Growing As A Company?

Data Unavailable

Mereo BioPharma Group PLC Stock Price Performance

What Is Mereo BioPharma Group PLC 52-Week High & Low?

Mereo BioPharma Group PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mereo BioPharma Group PLC?

Is Mereo BioPharma Group PLC Cash Flow Positive?

  • What Is MREO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30.2M
  • What Is Mereo BioPharma Group PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Mereo BioPharma Group PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$699K

Mereo BioPharma Group PLC Return On Invested Capital

Data Unavailable

Mereo BioPharma Group PLC Earnings Date & Stock Price

Mereo BioPharma Group PLC Competitors

Mereo BioPharma Group PLC Dividend Yield

Mereo BioPharma Group PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.9%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.18
Upside from Last Price: 95.2%

Major Shareholders

  • How many MREO shares are owned by institutional investors?
    104.1M MREO shares are owned by institutional investors
  • How many MREO shares are owned by insiders?
    4.7M MREO shares are owned by insiders